Craft

Better Therapeutics

Stock Price

$0

2024-03-25

Market Capitalization

$954 K

2024-03-25

Better Therapeutics Summary

Company Summary

Overview
Better Therapeutics (formerly known as FareWell) is a prescription digital therapeutics company that develops behavioral therapy. Its products include AspyreRx a self-paced, engaging treatment experience that patients can access therapy lessons, skill-building modules, weekly goal setting, and tracking, patients connect changes in behavior to improvements in blood sugar and other biometrics.
Type
Public
Status
Active
Founded
2015
HQ
San Francisco, CA, US | view all locations
Website
https://www.bettertx.com
Cybersecurity rating
Sectors

Key People

  • Frank Karbe

    Frank Karbe, Chief Executive Officer, Director

  • Mark Berman

    Mark Berman, Chief Medical Officer

  • Kristin Wynholds

    Kristin Wynholds, Chief Product Officer

  • Diane Gomez-Thinnes

    Diane Gomez-Thinnes, Chief Commercial Officer

LocationsView all

1 location detected

  • San Francisco, CA HQ

    United States

    548 Market St

Better Therapeutics Financials

Summary Financials

Net income (Q3, 2023)
($5.9M)
Cash (Q3, 2023)
$6.6M
EBIT (Q3, 2023)
($5.3M)
Enterprise value
$8.7M

Footer menu